Search
Descriptor English: Spiramycin
Descriptor Spanish: Espiramicina
Descriptor espiramicina
Entry term(s) adipato de espiramicina
Scope note: Antibiótico macrólido producido por Streptomyces ambofaciens. Este antibiótico es eficaz contra patógenos aerobios grampositivos, N. gonorrhoeae y estafilococos. Se utiliza en el tratamiento de infecciones causadas por bacterias y Toxoplasma gondii.
Descriptor Portuguese: Espiramicina
Descriptor French: Spiramycine
Entry term(s): Antibiotic 799
IL 5902
IL-5902
IL5902
NSC 55926
NSC 64393
NSC-55926
NSC-64393
NSC55926
NSC64393
Rovamycin
Rovamycine
Selectomycin
Spiramycin Adipate
Spiramycine
Tree number(s): D02.540.576.500.999.725
RDF Unique Identifier: https://id.nlm.nih.gov/mesh/D015572
Scope note: A macrolide antibiotic produced by Streptomyces ambofaciens. The drug is effective against gram-positive aerobic pathogens, N. gonorrhoeae, and staphylococci. It is used to treat infections caused by bacteria and Toxoplasma gondii.
Annotation: do not use /biosyn unless by living matter
Allowable Qualifiers: AA analogs & derivatives
AD administration & dosage
AE adverse effects
AG agonists
AI antagonists & inhibitors
AN analysis
BI biosynthesis
BL blood
CF cerebrospinal fluid
CH chemistry
CL classification
CS chemical synthesis
EC economics
HI history
IM immunology
IP isolation & purification
ME metabolism
PD pharmacology
PK pharmacokinetics
PO poisoning
RE radiation effects
SD supply & distribution
ST standards
TO toxicity
TU therapeutic use
UR urine
Pharm Action: Anti-Bacterial Agents
Coccidiostats
Registry Number: 8025-81-8
CAS Type 1 Name: Spiramycin
Previous Indexing: Leucomycins (1981-1989)
Public MeSH Note: 90; was see LEUCOMYCINS 1981-89; was heading 1963-80
Online Note: use LEUCOMYCINS to search SPIRAMYCIN 1981-89
History Note: 90; was see LEUCOMYCINS 1981-89; was heading 1963-80
DeCS ID: 24883
Unique ID: D015572
Documents indexed in the Virtual Health Library (VHL): Click here to access the VHL documents
Date Established: 1990/01/01
Date of Entry: 1989/05/25
Revision Date: 2016/07/01
Spiramycin - Preferred
Concept UI M0023923
Scope note A macrolide antibiotic produced by Streptomyces ambofaciens. The drug is effective against gram-positive aerobic pathogens, N. gonorrhoeae, and staphylococci. It is used to treat infections caused by bacteria and Toxoplasma gondii.
Preferred term Spiramycin
Entry term(s) Spiramycine
IL-5902 - Narrower
Concept UI M0352032
Preferred term IL-5902
Entry term(s) IL 5902
IL5902
Rovamycine - Narrower
Concept UI M0475714
Preferred term Rovamycine
Entry term(s) Selectomycin
NSC-64393 - Narrower
Concept UI M0023925
Preferred term NSC-64393
Entry term(s) NSC 64393
NSC64393
Rovamycin - Narrower
Concept UI M0352030
Preferred term Rovamycin
Spiramycin Adipate - Narrower
Concept UI M0023924
Preferred term Spiramycin Adipate
Antibiotic 799 - Narrower
Concept UI M0352033
Preferred term Antibiotic 799
NSC-55926 - Narrower
Concept UI M0352031
Preferred term NSC-55926
Entry term(s) NSC 55926
NSC55926



We want your feedback on the new DeCS / MeSH website

We invite you to complete a survey that will take no more than 3 minutes.

Go to survey